These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1080867)

  • 1. [The cellular immunological status as a prognostic factor in non-Hodgkin lymphomas].
    García-Puche JL; Pérez-Alférez N; Muñóz E; Garrido F; Osorio C
    Rev Clin Esp; 1975 Jul; 138(2):163-8. PubMed ID: 1080867
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytomegalovirus-specific immune response and the cellular immune status of malignant lymphoma.
    ten Napel CH; van Egten-Bijker J; Halie MR; Langenhuysen MM; The TH
    J Clin Lab Immunol; 1980 Nov; 4(3):145-51. PubMed ID: 6259357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [T and b lymphocytes. II. Sequential valuation in the course of leukaemia and lymphoma (author's transl)].
    Pozzi DH; Jamra M; Musatti CC; Tolnai ME; Figueiredo Mendes N
    Sangre (Barc); 1975; 20(3):311-22. PubMed ID: 1081741
    [No Abstract]   [Full Text] [Related]  

  • 4. [T and B lymphocytes. I. Assessment in leukaemia and lymphoma (author's transl)].
    Jamra M; Pozzi DH; Musatti CC; Tolnai ME; Figueiredo Mendes N
    Sangre (Barc); 1975; 20(3):273-87. PubMed ID: 1081740
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum and immunological studies in patients with lymphomas. 13. Examination of cellular immunity by specific and nonspecific stimulants].
    Giraudo Conesa LC; Braun M; Pavlovsky A; Bachmann AE
    Sangre (Barc); 1973; 18(3):305-12. PubMed ID: 4800716
    [No Abstract]   [Full Text] [Related]  

  • 6. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. II. Reticulosarcoma. (Correlation with the immunity reaction of the cellular type and the clinical status).
    Libánský J; Sedlácková M; Pinosová I
    Neoplasma; 1973; 20(1):61-7. PubMed ID: 4573872
    [No Abstract]   [Full Text] [Related]  

  • 7. Blastogenic transformation of lymphocytes following phytohaemagglutinin treatment in vitro in malignant lymphomas. I. Hodgkin's disease. (Correlation with immunity response of the cellular type and with the clinical status).
    Libánský J; Lukásová M; Pinosová I
    Neoplasma; 1973; 20(1):51-60. PubMed ID: 4702205
    [No Abstract]   [Full Text] [Related]  

  • 8. [Stimulation of cellular immunity in patients with malignant tumors].
    Govallo VI; Grigor'eva MP; Kosmiadi GA; Vostrikova NA
    Vopr Onkol; 1973; 19(12):30-4. PubMed ID: 4544936
    [No Abstract]   [Full Text] [Related]  

  • 9. Blood B and T lymphocytes and in vitro cellular immune reactivity in untreated human malignant lymphomas and other malignant tumors.
    Heier HE; Klepp R; Gundersen S; Godal T; Normann T
    Scand J Haematol; 1977 Feb; 18(2):137-48. PubMed ID: 138931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunological competence of subjects with sarcoidosis.
    Mangi RJ; Dwyer JM; Gee B; Kantor FS
    Clin Exp Immunol; 1974 Dec; 18(4):505-17. PubMed ID: 4283120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Normal immune function in centroblastic-centrocytic and centroblastic lymphoma].
    Weisbach V; Zeiler T; Zingsem J; Heuft HG; Mempel W; Wilmanns W; Eckstein R
    Beitr Infusionsther; 1990; 26():277-9. PubMed ID: 1703851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte populations in peripheral blood in hyperthyroid and euthyroid subjects.
    Lundell G; Wasserman J; Granberg PO; Blomgren H
    Clin Exp Immunol; 1976 Jan; 23(1):33-9. PubMed ID: 1083317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunity, leukemias and lymphomas. IV. Study of immunological reactivity in malignant granuloma in relationship to the histological type].
    Danieli G; Malini PL; Montroni M; Cremonini G; Lauria F
    G Clin Med; 1972 May; 53(5):250-61. PubMed ID: 4655304
    [No Abstract]   [Full Text] [Related]  

  • 14. Delayed cutaneous hypersensitivity and blood lymphocyte count in advanced Hodgkin's and non-Hodgkin's lymphomas.
    Gupta S; Seth SK; Udupa KN; Sen PC; Rastogi BL
    Ann Chir Gynaecol; 1980; 69(2):79-83. PubMed ID: 7377739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological reactivity in nonlymphogranulomatous malignant lymphomas].
    Loginskiĭ VE
    Klin Med (Mosk); 1980 Nov; 58(11):87-92. PubMed ID: 7453122
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunological profile in patients with non-Hodgkin's lymphomas.
    Urasiński I; Fiedorowicz-Fabrycy I; Sochacka-Kuzko B; Wichert K
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):467-74. PubMed ID: 6689470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunological status of patients with solid neoplasms].
    Citterio F; Luciani G; Pozzetto U; Castagneto M
    Minerva Chir; 1980 May; 35(10):717-22. PubMed ID: 6969868
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunity, leukemias and lymphomas. 5. Effects of splenectomy on the immunological condition of patients with malignant granuloma].
    Danieli G; Malini PL; Montro NI M; Cremonini G; Lauria F; Tura S
    G Clin Med; 1972 Jun; 53(6):277-89. PubMed ID: 4655306
    [No Abstract]   [Full Text] [Related]  

  • 19. B lymphocytes in untreated patients with malignant lymphoma and Hodgkin's disease.
    Gajl-Peczalska KJ; Hansen JA; Bloomfield CD; Good RA
    J Clin Invest; 1973 Dec; 52(12):3064-73. PubMed ID: 4201499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cimetidine does not influence immunological parameters in man.
    ten Berge RJ; de Pauw BE; Smeulders J; Wagener DJ
    Clin Immunol Immunopathol; 1981 Oct; 21(1):33-8. PubMed ID: 6456100
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.